The Receptor AXL Diversifies EGFR Signaling and Limits the Response to EGFR-Targeted Inhibitors in Triple-Negative Breast Cancer Cells
The relationship between drug resistance, changes in signaling, and emergence of an invasive phenotype is well appreciated, but the underlying mechanisms are not well understood. Using machine learning analysis applied to the Cancer Cell Line Encyclopedia database, we identified expression of AXL, t...
| Main Authors: | , , , |
|---|---|
| Outros Autores: | |
| Formato: | Artigo |
| Idioma: | en_US |
| Publicado em: |
American Association for the Advancement of Science (AAAS)
2014
|
| Acesso em linha: | http://hdl.handle.net/1721.1/88954 https://orcid.org/0000-0003-3214-4554 |